ATE505199T1 - Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser - Google Patents

Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser

Info

Publication number
ATE505199T1
ATE505199T1 AT03767892T AT03767892T ATE505199T1 AT E505199 T1 ATE505199 T1 AT E505199T1 AT 03767892 T AT03767892 T AT 03767892T AT 03767892 T AT03767892 T AT 03767892T AT E505199 T1 ATE505199 T1 AT E505199T1
Authority
AT
Austria
Prior art keywords
cosmetic
gly
arg
pharmaceutical
compositions containing
Prior art date
Application number
AT03767892T
Other languages
English (en)
Inventor
Farra Claude Dal
Nouha Domloge
Jean-Marie Botto
Original Assignee
Soc Extraction Principes Actif
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0214012A external-priority patent/FR2846883B1/fr
Priority claimed from FR0309889A external-priority patent/FR2858769B1/fr
Application filed by Soc Extraction Principes Actif filed Critical Soc Extraction Principes Actif
Application granted granted Critical
Publication of ATE505199T1 publication Critical patent/ATE505199T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03767892T 2002-11-08 2003-11-04 Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser ATE505199T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0214012A FR2846883B1 (fr) 2002-11-08 2002-11-08 Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide
FR0309889A FR2858769B1 (fr) 2003-08-13 2003-08-13 Utilisation d'un peptide comme principe actif amincissant
PCT/FR2003/003280 WO2004043482A1 (fr) 2002-11-08 2003-11-04 Composition cosmetique ou pharmaceutique comprenant des peptides, possedant le motif arg-gly-ser

Publications (1)

Publication Number Publication Date
ATE505199T1 true ATE505199T1 (de) 2011-04-15

Family

ID=32313954

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03767892T ATE505199T1 (de) 2002-11-08 2003-11-04 Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser

Country Status (6)

Country Link
US (2) US7504092B2 (de)
EP (1) EP1575605B1 (de)
AT (1) ATE505199T1 (de)
AU (1) AU2003292326A1 (de)
DE (1) DE60336756D1 (de)
WO (1) WO2004043482A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101516903B (zh) * 2006-07-21 2014-01-01 百帝森萨股份公司 用于制造肽的方法
FR2907682B1 (fr) * 2006-10-26 2012-12-07 Vincience Composition cosmetique et/ou pharmaceutique comprenant comme principe actif au moins un peptide et utilisation de ce peptide.
FR2915382B1 (fr) * 2007-04-27 2012-06-01 Vincience Utilisation d'un principe actif issu du mais (zea mays l) pour preparer une composition destinee a activer le cytochrome c
FR2915395B1 (fr) * 2007-04-27 2012-03-09 Vincience Composition pharmaceutique et/ou cosmetique contenant des peptides
FR2915391B1 (fr) * 2007-04-27 2011-08-12 Soc Extraction Principes Actif Composition pharmaceutique et/ou cosmetique contenant un principe actif antioxydant et activateur de l'energie cellulaire.
FR2915394B1 (fr) * 2007-04-27 2012-12-14 Vincience Composition pharmaceutique et/ou cosmetique contenant des peptides
FR2915393B1 (fr) * 2007-04-27 2012-12-14 Vincience Composition pharmaceutique et/ou cosmetique contenant un principe actif activateur du cytochrome c
FR2915396B1 (fr) * 2007-04-27 2012-01-20 Vincience Composition pharmaceutique et/ou cosmetique contenant des peptides
FR2915397B1 (fr) * 2007-04-27 2012-01-20 Vincience Composition pharmaceutique et/ou cosmetique contenant des principes actifs activateurs de l'aconitase
FR2915385B1 (fr) * 2007-04-27 2012-09-28 Vincience Utilisation d'un principe actif issu de l'amarante (amaranthus) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
PH12017501070B1 (en) * 2014-12-23 2022-04-29 Avon Prod Inc Peptides and their use in the treatment of skin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821231A (en) * 1993-12-06 1998-10-13 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using same
FR2738746B1 (fr) * 1995-09-19 1997-11-14 Oreal Utilisation d'au moins un peptide dans une composition cosmetique ou pour la preparation d'un medicament
DE19653736C2 (de) * 1996-12-12 2002-11-21 Lancaster Group Gmbh Kosmetisches Präparat mit Peptidzusatz
US6228989B1 (en) * 1998-11-13 2001-05-08 The Regents Of The University Of California Peptide substrates phosphorylated by P21-activated protein kinase
FR2788777B1 (fr) * 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
WO2000077042A2 (en) * 1999-06-15 2000-12-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Parathyroid hormone receptor ligands
FR2827170B1 (fr) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
US20050181474A1 (en) * 2002-01-30 2005-08-18 Frank J. Giordano Transport peptides and uses therefor

Also Published As

Publication number Publication date
EP1575605A1 (de) 2005-09-21
US20060013794A1 (en) 2006-01-19
WO2004043482A1 (fr) 2004-05-27
US20080227725A1 (en) 2008-09-18
DE60336756D1 (de) 2011-05-26
US7674451B2 (en) 2010-03-09
EP1575605B1 (de) 2011-04-13
US7504092B2 (en) 2009-03-17
AU2003292326A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
ES2285859T3 (es) Utilizacion cosmetica o dermofarmaceutica de peptidos para la cicatrizacion, la hidratacion y la mejora del aspecto cutaneo durante el envejecimiento natural o acelerado (heliodermia, contaminacion).
US7834055B2 (en) Compositions and methods for the treatment of skin
ES2108110T3 (es) Composiciones terapeuticas y cosmeticas para el tratamiento de la piel.
WO1996019099A3 (fr) Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
DE58901401D1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
ES2102921T3 (es) Utilizacion de derivados de la hormona estimuladora de los melanocitos de tipo alfa para estimular el crecimiento de los cabellos.
ATE505199T1 (de) Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser
KR960000855A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
DE50012571D1 (de) Biotin enthaltende galenische formulierung
KR960010002A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
DE69400353D1 (de) Schlankmachende Zusammensetzung
ATE393631T1 (de) Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen
ATE392428T1 (de) Arzneimittel enthaltend analgetische peptide
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
KR101715599B1 (ko) 지방산이 결합된 트리펩타이드 및 이를 포함하는 주름 개선용 화장료 조성물
BR9708297A (pt) Compostos composição farmacéutica cosmposição e uso de uma composição cosmética
KR960010003A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
DE69717311D1 (de) Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts
US20100098732A1 (en) Methods, processes and compositions comprising the protein calmodulin (cam) for treatment of damaged or aging skin, and/or hair loss
WO2002069884A2 (en) A sunburn treatment and sunburn prevention method
US20230355493A1 (en) Topical composition
JP2023519935A (ja) 皮膚症状に用いるためのアセチルコリンエステラーゼのｃ末端に由来するポリペプチド
RU2004129586A (ru) Фармацевтические и косметические композиции, содержащие плацентарный фактор роста plgf-1
BRPI0414734A (pt) introdução de cosméticos na pele

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties